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Abstract 
Timely, reliable and complete information on financial resources in the health sector is 
critical for sound policy making and planning, particularly in developing countries where 
resources are both scarce and unpredictable. Health resource tracking has a long history 
and has seen renewed interest more recently as pressure has mounted to improve 
accountability for the attainment of the health MDGs. We review the methods used to 
track health resources and recent experiences of their application, with a view to 
identifying the major challenges that must be overcome if data availability and reliability 
are to improve.  
 
At the country level, there have been important advances in the refinement of the 
National Health Accounts methodology, which is now regarded as the international 
standard. Significant efforts have also been put into the development of methods to track 
disease-specific expenditures. However, NHA as a framework can do little to address the 
underlying problem of weak government public expenditure management and 
information systems that provide much of the raw data. The experience of 
institutionalising NHA suggests progress has been uneven and there is a potential for 
stand-alone disease accounts to make the situation worse by undermining capacity and 
confusing technicians. Global level tracking of donor assistance to health relies to a large 
extent on the OECD’s Creditor Reporting System. Despite improvements in its coverage 
and reliability, the demand for estimates of aid to control of specific diseases is resulting 
in multiple, uncoordinated data requests to donor agencies, placing additional workload 
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on the providers of information. The emergence of budget support aid modalities poses a 
methodological challenge to health resource tracking, as such support is difficult to 
attribute to any particular sector or health programme.  
 
Attention should focus on improving underlying financial and information systems at the 
country level, which will facilitate more reliable and timely reporting of NHA estimates. 
Effective implementation of a framework to make donors more accountable to recipient 
countries and the international community will improve availability of financial data on 
their activities. 
 
Keywords  
 
Key Messages 
 Health resource tracking in developing countries has seen substantial 
advancements over the years in the standardisation of methods, providing more 
reliable information to influence decision-makers and improve health system 
performance. 
 Important gaps in information on the flow of resources to health remain, most of 
all in the coverage of reliable National Health Accounts estimates. The major 
challenges that exist relate to weak underlying systems and linkages, 
methodological limitations, implementation constraints and getting evidence into 
policy. 
 Improvement in the functioning of public expenditure management systems of 
developing countries is the priority and will be influenced most by domestic 
pressure for greater accountability. Donors have a clear role to play in capacity 
building and providing recipient governments with timely data on their aid 
activities.  
 
I. Introduction 
Timely, reliable and complete information on financial resources in the health sector is 
critical for sound policy making and planning. The need for such data exists the world 
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over, but no more so than in developing countries. When available resources are 
substantially less than needs, allocation decisions are all the more important and in many 
aid dependent countries planning is further complicated by volatile aid flows, and 
subsequent uncertainty over available health resources (Bulir and Hamann 2001). Yet it 
is in these countries where the greatest gaps in data on health resources exist. Without 
accurate information on the size and distribution of available funds, resources are 
unlikely to be allocated in a way that reflects a country’s priority health needs, hampering 
efforts to deliver health services that improve the population’s health status and standard 
of living.  
 
Efforts to collect and analyse data on the flow of health funds, referred to now as health 
resource tracking, began in the 1950s with some national surveys in developed countries 
focusing on some sources of finance only (ILO 1959, ISSA 1961). The first systematic 
and comprehensive survey was done by Abel Smith in 6 countries, including Sri Lanka 
and Chile (Abel-Smith 1963). Based on the encouraging results of this first survey, 
another larger study was commissioned of 29 countries, 21 of them developing countries 
(Abel-Smith 1967). 
 
This study stimulated further experimentation and methodological development, with 
developed countries initially moving ahead faster than developing countries (Griffiths 
and Mills 1983). However during the 1970s there was growing experimentation with 
health financing and expenditure surveys in developing countries (Kam, et al. 1977, 
WHO 1978), and the development of a number of manuals (Griffiths and Mills 1982, 
Mach and Abel-Smith 1983, Roberston, et al. 1979).  Since then, health accounting at the 
country level has become more standardised in the form of the National Health Accounts 
(NHA) methodology, and the value of such data more widely appreciated.  
 
Most recently there has been renewed interest in health resource tracking at the global 
level, where a preoccupation of advocates has been to use such information to campaign 
for increased international aid and to hold the donor community more accountable to 
their commitments (Levine 2006). The emergence of the Millennium Development Goals 
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(MDG) as the focal point of international development has prompted some, quite rightly, 
to ask how much money is required to reach these targets and how much is currently 
spent. In addition, donors are demanding more reliable data on health spending in 
recipient countries to compare against programme performance, and there is a growing 
consensus that the health MDGs will not be achieved unless more resources are 
mobilised and better spent. This requires a robust evidence base.  
 
Aside from the interest of donors, recommendations from the High Level Forum for the 
Health MDGs indicate that developing countries are keen to improve data on financial 
resources in health and wish to see this issue given greater prominence (HLF 2004). 
Reflecting collective concerns over the current state of health resource tracking, an 
independent think tank, the Center for Global Development (CGD), has set up a working 
group of experts to identify ways of improving data on financial flows in the health sector 
in developing countries.  
 
The purpose of this paper is to examine how health resources can be tracked to fulfil the 
information needs of those who make or influence policy, whether they be government 
officials in developing countries, technicians (including researchers), donors, advocacy 
groups or politicians (Levine and Blumer 2004). First, we describe how data on health 
resources are used. Second, based on the findings of a literature review, we give an 
overview of the various approaches to health resource tracking and then examine the 
major challenges that exist. We conclude with a discussion on ways in which data 
collection efforts can be improved and better integrated so as to make health resource 
tracking more effective and responsive to demands.  
 
2. Search strategy 
We searched PubMed for literature published from January 1966 to May 2006. The 
search terms used were: (health) AND (donor support OR international aid OR 
international spending OR financial flows OR health expenditure* OR health account* 
OR financial account*) AND (Africa OR Asia OR Latin OR Caribbean OR Soviet OR 
Eastern Europe OR OECD). The searches were limited to English language literature 
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dealing with human subjects. We also performed internet searches for grey literature, 
reviewing the websites of the following organisations working in health resource 
tracking: WHO, OECD, PAHO, Center for Global Development, Partnerships for Health 
Reform, Overseas Development Institute, World Bank, International Monetary Fund and 
DFID Health Systems Resource Centre.  
 
Our search produced 1118 publications of potential relevance in PubMed. If the titles or 
abstracts of these articles made any reference to methods used in tracking health 
resources, they were deemed relevant. Reference lists of the identified references were 
reviewed for additional publications. We identified and reviewed 13 publications of 
relevance. 
 
3. Purpose of health resource tracking 
The goal of health resource tracking is to inform the decision-making process and thereby 
enhance health system performance. It provides the evidence base for improved policy 
development, planning, and implementation. More specifically, information on the flow 
of funds is used for resource allocation, resource mobilisation, stewardship, 
understanding distributional fairness and the development of financing strategies (WHO 
2003, Levine and Blumer 2004, PHRplus 2004).  
 
A central concern of policymakers is how to allocate scarce health resources. To do so 
effectively requires an understanding of the allocation of funds along different 
dimensions of the health system – health services, provider levels, interventions and 
disease categories – and to what extent these reflect health priorities and / or government 
policies in a country. It can also measure the actual success of policies to shift resource 
priorities (WHO 2003). NHA data in South Africa, for example, has contributed to the 
debate on the geographical allocation of government health resources and means of 
redressing related inequities (personal communication, Lucy Gilson) (De, et al. 2003). 
The issue of what sort of breakdowns of health financing data are most informative lies at 
the heart of health resource tracking.  
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Health resource tracking is used to quantify the adequacy of funds in terms of the gap 
between what is currently being spent and what is required. Such information can be used 
as a powerful advocacy tool to mobilise additional health resources, whether it be in the 
annual budget discussions between a Ministry of Health and Ministry of Finance or by an 
advocacy group pressuring the international donor community. Knowing where funds are 
mobilised from can also inform strategies to raise additional health resources. Data on 
donor disbursements to maternal, newborn and child health, for example, were recently 
used to re- invigorate commitments to MDGs 4 and 5.  
 
Effective stewardship of a health system requires an understanding of how health 
resources are managed. This can help to improve coordination of actors and avoid 
duplication of effort to ensure the efficient use of scarce resources. This issue is 
particularly pertinent in the context of development aid, where the re are often numerous 
external donors and NGOs working in health (Levine and Blumer 2004). If a government 
sees there is poor coordination in the allocation of health resources, it may wish to use 
mechanisms such as a Sector-Wide Approach (SWAp) to align support more closely to 
its stated policy priorities. NHA data from Rwanda has shown that a significant 
proportion of funds are spent off-budget undermining government stewardship of the 
health sector. As expected, expenditure on administration is considerable, and there is a 
misallocation of resources towards HIV/AIDS at the expense of greater burdens of 
disease such as malaria and childhood illnesses (Foster and Killick 2006). 
 
Assessing who benefits from expenditure on health care is important for understanding 
whether the allocation of funds results in benefits reaching their intended target group 
(WHO 2003). While allocation decisions may be well intentioned, the beneficiaries, for 
implementation reasons, may not always be those intended. The application of benefit 
incidence analysis examines who are the beneficiaries of health care expenditure between 
various client and population groups (Wagstaff and van Doorslaer 1993), drawing on not 
only expenditure data but also data on health service utilisation and target groups.  
Groups may be defined in terms of geographical location, age, gender, or ethnicity, but 
typically a benefit incidence analysis uses a measure of living standards, such as income 
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or wealth (Pearson 2002). Although examining the distribution of health expenditure 
across socio-economic groups is still relatively uncommon in developing countries, there 
are examples of its use, such as the cross country comparison of equity in public health 
spending in Asia (O'Donnell, et al. 2005). 
 
Last, analysis of health expenditure data is a critical input into the development of 
financing strategies. Knowing who finances health services, how they pay for it, and the 
relative size of the financial burden provides insight into the fairness of health financing, 
and the extent to which risk pooling and financing mechanisms protect against 
catastrophic health payments and their impoverishing effects (Wagstaff and van 
Doorslaer 1993, WHO 2003). The fairness of financing contribution has been identified 
as a key dimension of health system performance (WHO 2000). In developing countries, 
where evidence suggests out-of-pocket payments exacerbate poverty (van Doorslaer, et 
al. 2006), the development of financing strategies that protect the poor is a pressing need. 
More broadly, the balance between public, private and external financing in a health 
system can have implications for sustainability, and again equity.  
 
The most common types of financial data gathered by health resource tracking systems 
include budgets, commitments, disbursements and expenditures. Budget data show the 
estimated resources available and the amount planned to be spent, while commitments 
measure the amount of funds to be drawn down over time, indicating a firm decision or 
promise to spend money (Eiseman and Fossum 2005). Although disbursements and 
expenditures are both retrospective types of data, in the context of international aid, a 
distinction is made between the two. Disbursement data represent the placement of 
financial resources at the disposal of entities within a recipient country during a calendar 
year (OECD 2002), and expenditures measure the value of goods and services consumed 
within a country during a calendar year1.  
 
                                                 
1
 Depending on the source of data, in some instances such as the case of drugs and supplies, expenditures 
may not measure the value of consumption since the cost is registered when purchased not when consumed. 
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Expenditure data provide the most accurate assessment of the financial status of a health 
system, and reflect the actual financial cost of providing services (PHRplus 2004). They 
are also the most difficult and sensitive type of financial data to gather. Audited data are 
typically available after 6 to 12 months from the end of the fiscal year. Though funds 
may be budgeted or committed, it is by no means guaranteed that they translate into 
expenditures owing to delays in disbursement and outright cancellations. In other words, 
budget data are not necessarily an accurate reflection of how resources are used, 
particularly in countries where capacity to plan and implement is weak.  
 
4. Approaches to health resource tracking 
When reviewing the various methods employed for health resource tracking, we followed 
Eisman and Fossum (2005) in making the distinction between those that collect data on 
global aid flows to developing countries and those that track domestic resources within 
developing countries, for these two sets of information are used at different levels of 
decision-making.  
 
Country level 
At the country level, the internationally accepted methodology for analysing the flow of 
health resources is the system of National Health Accounts (WHO 2003), founded on the 
OECD System of Health Accounts (OECD 2000). The methods were first pioneered in 
OECD countries (Schieber and Poullier 1986), and later applied to developing countries 
(Berman 1997). They represent the culmination of over 15 years of experience in health 
accounting, establishing a systematic, consistent, and comprehensive approach to 
measuring health expenditure within a country (Poullier, et al. 2003). NHA analyses the 
flow of health resources through the entire health system from the source of financing to 
the end purchase of health care goods and services. To date, NHAs have been conducted 
at least once in almost 70 countries (PHRplus 2004), of which approximately 30 are 
developing countries (WHO 2006b). 
(www.who.int/nha/docs/country/en/index.html).  
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NHA is essentially a framework to classify expenditures within a health system. It links 
the flow of funds within a matrix between two dimensions. NHA, at the most basic level, 
tracks funding flows between four possible dimensions: financing sources; financing 
agents; health providers; and functions. The functions refer to categories of ‘types of 
goods and services produced by health care providers and by institutions and actors 
engaged in related activities to health care’ (WHO 2003). NHA relies on data collected 
from both primary and secondary sources including government ministries, social 
security agencies, households, private companies, insurers, donor organisations, NGOs, 
health care providers and pharmaceutical retailers. The matrix design of NHA tables 
means that for any single entry, there are likely to be at least two sources of data which 
can be cross-checked to generate the most reliable expenditure estimate available. 
Ideally, all data should be available ‘off the shelf.’ However, in practice, surveys and 
interview schedules are required to fill data gaps.  
 
WHO publish annually a basic set of 16 policy-relevant NHA indicators for all member 
states, in the first instance drawing on national health accounts reports or OECD health 
data and, if unavailable, public expenditure reports, budgetary reports, other government 
documents, household surveys and other sources (WHO 2006a). This dataset represents 
the most complete and detailed set of country level data on health expenditures and is 
supplemented by disaggregated data available online (WHO 2006b). The Pan-American 
Health Organisation (PAHO 2005), OECD (OECD 2004) and World Bank (World Bank 
2006) also maintain separate databases on health accounts. However, these databases are 
not consistent in their reporting of statistics.  
 
The NHA framework and classifications are sufficiently flexible to track disease and 
population-group specific health expenditures. These sub-accounts, as the name suggests, 
are undertaken as part of an overall NHA in which total health expenditures are allocated 
across priority disease groupings based on International Classification of Diseases 
definitions. They capture specific expenditures rela ted to the disease or population group 
in question as well as integrated health funds, prorated on the basis of utilisation and cost 
information. Work has been undertaken to develop and standardise methods in the 
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measurement of HIV/AIDS (De, et al. 2004), malaria, reproductive health and child 
health expenditures (Expert Group on Child Health Accounts 2005) using the NHA 
framework. 
 
Independently, the Regional AIDS Initiative for Latin America and the Caribbean 
(SIDALAC) has developed National HIV/AIDS Accounts, which has been used across 
Central and Latin America (Izazola-Licea, et al. 2002). The classifications used, despite 
not adhering to the precise dimensions of the NHA framework, closely match those of the 
HIV/AIDS sub-accounts at the level of functions. The major difference lies in the 
approach; National HIV/AIDS Accounts are conducted as stand-alone exercises.  
 
Financial data on immunisation activities are collected for approximately 40 deve loping 
countries as a requirement in the Financial Sustainability Plans submitted to GAVI 
(WHO 2006c). The database includes information on both past expenditures and future 
resource requirements. It is possible to disaggregate expenditures by source of financing 
(closest to the end use) and type of input. The methods serve to track immunisation 
specific funds only, and there is no attempt to include expenditures on shared inputs 
(WHO 2006d). 
 
Since in-country health resource tracking methods rely on public expenditure 
management (PEM) systems for data on government expenditures, it is worth considering 
how these have evolved in recent years in developing countries. In parallel with the 
development of Poverty Reduction Strategy Papers (PRSP) in the Highly Indebted Poor 
Countries (HIPC), many governments reformed their PEM systems towards performance 
based budgeting and the establishment of medium term expenditure frameworks (MTEF). 
Performance budgeting is the planning of public expenditures towards the achievement of 
specified results that are linked explicitly to policy objectives. It evolved out of the 
planning, programming, budgeting system (PPBS), first developed in the US during 
World War II, and adopted most ardently by the US Defence Department to improve 
efficiency and address the disconnect between budgeting and planning (Rose 2005). 
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Performance budgeting has now been adopted in many OECD countries, although the 
specific focus of these systems differs widely across national governments (Rose 2005).  
 
The adoption of MTEFs in many developing countries does not imply per se that there 
has been a simultaneous upgrading of financial accounting and auditing procedures to 
provide more reliable expenditure data. Indeed mature performance budgeting systems 
coexist with poor financial accountability, largely because most of the progress to date 
has been presentational rather than operational (Roberts 2003). It does mean, however, 
that government health expenditures are linked to clearly defined outputs or activities and 
can therefore be categorised more easily into the functional classifications of NHA.  
 
In the absence of robust PEM systems, a number of developing countries have 
undertaken public expenditure tracking surveys (PETS). In contrast to the above health 
resource tracking methods, PETS seek to analyse delays in disbursements of public funds 
and the extent of misappropriations as funds flow from the time of release to the purchase 
of final goods and services (Dehn, et al. 2003).  
 
Global level 
The definitive source of data on aid flows to developing countries is the Creditor 
Reporting System (CRS) database, maintained and administered by the Development 
Assistance Committee (DAC) of the OECD. Although originally conceived to supply 
data on capital flows and indebtedness, it has evolved over time to give geographical and 
sectoral breakdowns of aid for 186 recipient countries (OECD 2002). It is accessible 
online and available to the public (OECD 2006a). 
 
DAC members (22 high income donor countries and the European Commission) and a 
growing number of multilateral organisations self-report to the CRS on individual project 
transactions, supplying financial and descriptive data on their aid activities, which a llows 
analysis of commitments and disbursements by year, donor, recipient country, type of 
flows (ie. grant or loan), and purpose of aid. Donors are guided in their reporting by a set 
of directives and definitions that in essence provide the methodological foundation for 
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tracking official aid flows (OECD 2001a, OECD 2002). The definition of health 
resources, however, differs slightly from total health expenditure, the statistic most 
commonly reported in NHA, by including medical education, training and research2. 
 
The DAC database, complementary to the CRS, provides aggregate estimates of aid 
flows and is useful in verifying the completeness of the CRS. In the 1990s, the coverage 
of ODA commitments reported to the CRS as a proportion of commitments reported to 
the DAC was approximately 75 to 80 percent (OECD 2001b). The coverage has 
improved markedly to 92 percent for the database as a whole and 100 percent for the 
health sector in 2002 (OECD 2006b, OECD 2006c). 
 
The DAC and CRS have been used to analyse global trends in international aid to the 
health sector (Michaud and Murray 1994). Despite being designed originally to monitor 
broad sectoral flows, data in the CRS have also been exploited extensively in a plethora 
of studies tracking global levels of Official Development Assistance (ODA) to specific 
health programmes – including population activities3 (OECD 2004, Ethleston, et al. 2004, 
MacKellar 2005, Reuser, et al. 2004, UNAIDS 2005); malaria (Narasimhan and Attaran 
2003, Waddington, et al. 2005); TB (WHO 2005); and maternal, newborn and child 
health (Powell-Jackson, et al. 2006).  
 
Many of the studies have sought to supplement and validate CRS data with direct 
requests for information from bilateral and multilateral organisations, as well as other 
organisations such as foundations, NGOs and private companies, whose private aid 
transactions are not captured by the CRS. The Resource Flows database, maintained by 
the Netherlands Interdisciplinary Demographic Institute (NIDI) on behalf of UNFPA and 
UNAIDS, and studies on tuberculosis and health research, go one step further, tracking 
also developing countries’ domestic expenditures to population activities (UNFPA 2004, 
                                                 
2
 The NHA definit ion of national health expenditure does include research and training as health related 
expenses (HCR.2 and HCR.3)  
3
 Population activities are inclusive of family planning, basic reproductive health services, basic research 
and policy development, and HIV/AIDS 
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van Dalen and Reuser 2005), tuberculosis (WHO 2005) and health research (Global 
Forum for Health Research 2004) respectively.  
 
5. Challenges 
Currently, there are important gaps in information on the flow of resources to health. 
Application of NHA methods in OECD countries is widespread (OECD 2004) but at 
present remains limited in developing countries. Few developing countries report reliable 
NHA estimates on a regular and frequent basis and studies, on the whole, remain o ne-off 
exercises (WHO 2006b). Disbursement data in the CRS are incomplete, and the extent of 
reporting varies considerably between donors. The World Bank, for example, reports 
commitments only, while UN agencies report expenditures only. Moreover, with the 
focus of the CRS on ODA, there exists no systematic collection of data on external flows 
of private health funds to developing countries from foundations, individuals and 
companies – a source of growing importance.  
 
Ensuring timely, reliable and complete information on health resources faces a number of 
challenges and these are discussed along the following themes: weak underlying systems 
and linkages; methodological limitations; implementation constraints; and getting 
evidence into policy.  
 
Weak underlying systems and linkages 
Routine reporting of financial data must rely on underlying systems. The majority of 
information required for NHA should be available from secondary sources (PHRplus 
2004). An important concern relates to the reliability of data that NHA estimates are 
founded upon. PEM systems in low-income countries are often weak in terms of their 
capacity to account accurately for transactions, particularly at decentralised levels, as are 
data on health service utilisation, which are used to distribute health expenditures 
between different functions. A joint review by the International Monetary Fund and 
World Bank of the PEM systems of HIPC countries, for example, found that 16 out of the 
25 study countries required substantial upgrading and almost all countries had inadequate 
auditing procedures (IMF and IDA 2001).  
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Private health expenditures have, in the past, been overlooked (Chawla, et al. 1998), and 
remain difficult to obtain for practical reasons. Health management information systems 
occasionally record user fee revenues within the public health system, but rarely cover 
private health institutions and private pharmacies. Health spending questions have been 
incorporated into household surveys, such as the Living Standards Measurement Surveys, 
in some countries (Hotchkiss, et al. 1998). These can provide valuable and reliable 
information on out-of-pocket health expenditures, but on an infrequent basis only. Only 
basic information is obtainable from such surveys, due to the multi-purpose nature of 
household surveys and the unreliability of responses to complex expenditure questions 
given the recall period required from respondents. 
 
The data problem is further compounded by the poor record of donor agencies in 
providing government authorities with accurate expenditure and commitment statistics on 
a routine basis (Foster and Killick 2006). In response, some countries have implemented 
external aid databases so as to consolidate all data collection activities from donors and 
NGOs into a routine, predictable process. These databases are designed to improve 
planning and to monitor the activities of external development partners in an effort to 
make these organisations more accountable to stakeholders in the recipient country. They 
are principally for the purposes of the Ministry of Finance, and therefore may not provide 
the level of detail required by a Ministry of Health for comprehensive sector level 
planning. The absence of reliable underlying routine systems has implications for the 
implementation of health resource tracking efforts, as discussed below.  
 
Global level tracking of development aid relies on the DAC system and CRS, which in 
turn draw their data from the existing financial systems of donor organisations. Here, the 
challenge is not so much related to weak systems but rather to standardising into one 
common format the information coming from the data management systems of over two 
dozen donors, who each use their own classifications. Linking their system to the CRS is 
a challenge for some donor organisations. 
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Methodological limitations 
The standardisation of the NHA methodology for country level health resource tracking 
is no small achievement. There have been a variety of health accounting approaches 
developed over the past 15 years (PAHO 2003) and it required a concerted effort, based 
on the input of a wide group of experts and practitioners with experience in applying the 
various methods, to reach a consensus on a standard methodology. Similarly, the CRS 
represents the establishment of a standard in the tracking of ODA to developing 
countries. There remains a limitation of the CRS in the manner projects are assigned to 
sectors on an ‘all or nothing’ basis. A project that supports more than one sector is 
categorised according to the sector receiving the majority of funds and the other sectors 
are deemed to receive nothing (Attaran and Sachs 2001, MacKellar 2005).  
 
Demand for expenditure data on specific diseases has increased in recent years and in 
response, methods have been developed to track these resource flows. Any disease 
expenditure tracking study, whether at the country level or on a global scale, will face the 
methodological challenge of apportioning funds channelled through integrated health 
services to the disease of interest. Accounting systems can categorise information in two 
ways – by type of resource (e.g. salaries, equipment) or management cost centre (e.g. 
health facility, vertical health programme). Adding a third level, such as disease 
categories, is not usually possible. One cannot expect health workers, for example, to fill 
out time sheets every day stating how much time they spend with HIV/AIDS patients. It 
is only practical to apportion funds to a disease in the analysis stage, using detailed health 
service utilisation and cost data, which may not always be available (Janowitz and 
Thompson 2001). 
 
At the country level, disease accounts are undertaken either as part of a broader NHA 
exercise or as a stand-alone study. If disease accounts are conducted outside of a general, 
overarching framework, there is the potential for the sum of the disease expenditures to 
exceed total national health expenditure. Moreover, it is questionable how reliably, if at 
all, stand-alone disease accounts can attribute integrated health funds to the disease in 
question without an appreciation of the overall health expenditure envelope.  
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The inability of many donors to report on expenditures to a specific disease is illustrative 
of the inherent tension between the data needs of policymakers and the practicalities of 
tracking resources (Ethleston, et al. 2004). For donors who use the majority of their 
budget to support health systems and the delivery of integrated health services, it would 
not be rational to structure their accounting system around disease categories or 
interventions. Poor transparency may also be to blame and, as is clear from a recent 
debate concerning the World Bank’s malaria programme, difficulties in reporting 
disease-specific spending might be explained by either (Attaran, et al. 2006, Sarbib, et al. 
2006). A further issue is that the information demanded from donors is often not in 
discrete categories. The tracking of maternal, newborn and child health, for instance, cuts 
across diseases and must use methods to apportion not only integrated health funds but 
also disease expenditures (Powell-Jackson, et al. 2006). The design of any accounting 
system is founded upon the classification of expenditures into discrete categories and the 
problem of disentangling expenditures on overlapping health programmes must be 
resolved in the analysis stage.  
 
A final methodological challenge in health resource tracking relates to the emergence of 
budgetary support and pooling mechanisms, used increasingly by some donors to 
disburse aid.  As these funds are disbursed through government, PEM systems have to be 
relied on for accounting purposes. Moreover, general budget support funds are 
completely fungible; hence it is difficult to attribute them to a specific sector without a 
complex time trend analysis of all sources of government revenue and expenditure by 
sector. Crude methods have been used to distribute budget support or pooled funds to 
specific diseases and demographic groups, but they provide indicative estimates only 
(Bruijn and Horstman 2005, Powell-Jackson, et al. 2006).  
 
This is not to argue that donors should not disburse aid through such mechanisms. The 
difficulties faced by health resource tracking are simply a reality of doing business this 
way. Indeed, the channelling of money through government systems should provide 
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donors with a stronger incentive to help improve government capacity to plan and 
account for public funds.  
 
Implementation constraints 
Missing data from secondary sources is a major barrier to implementation of NHA. When 
underlying systems are non-existent or the data weak, surveys must be undertaken to fill 
the void. Not only are surveys of government ministries, donors and private entities time-
consuming and costly, they do not contribute directly to system development. The 
problem is often government-wide, not soluble within a single sector, and as long as these 
data gaps continue to exist, NHAs will rely on questionnaires to collect information that 
should be available routinely, at the expense of timeliness and policy relevance.  
 
Institutionalisation is an important criterion that has been applied to NHA. Certainly, the 
establishment of an “organisational home and technical capacity to develop ongoing 
expenditure estimates” is critical for time series analyses (WHO 2003). Frequency in the 
reporting of NHA estimates suggests institutionalisation across countries has been 
uneven. Successful institutionalisation does not necessarily preclude external support, but 
given the unpredictability of donor funding and shifting priorities, the long run viability 
of NHA and regular reporting of estimates is likely to require governments eventually to 
bear the cost. An important consideration for the institutionalisation of NHA is who is 
best positioned within the country to undertake the work. Such a decision should be 
based on who has access to data, where capacity lies and who is most likely to influence 
the decision-making process at the top of government. Experience suggests central 
government is the most effective ‘home’ for the NHA team (WHO 2003). 
 
The DAC and CRS databases are long established systems. Coverage of commitments 
from the OECD member countries has improved, and other donor countries and 
multilateral agencies have integrated their reporting into the system. Nevertheless, a 
number of donors still fail to report complete information, which has led some to 
question the transparency of these organisations (Narasimhan and Attaran 2003). The 
slow pace at which coverage of the OECD’s CRS system has increased is perhaps 
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testament to the reluctance of donors to disclose information or to give disclosure 
priority, in combination with the absence of a robust system to ensure compliance with 
data requirements. 
 
Despite the apparent wide acceptance of the NHA methodology and CRS database, 
disease expenditure tracking studies that use parallel means of data collection and 
conflicting methods for the attainment of short-term objectives are still pursued and can 
risk compromising these systems. The ‘stand-alone’ approach, such as that proposed to 
measure HIV/AIDS expenditures by UNAIDS, has the potential to confuse and 
undermine capacity already built in NHA by promoting conflicting classification systems 
and methods (Dmytraczenko, et al. 2006). Therefore, for both methodological and 
implementation reasons, NHA should always be the basis for disease-specific studies. 
The demand for disease-specific estimates at the global level has manifested itself in 
multiple, uncoordinated data requests to donor agencies, placing additional workload on 
the providers of information. Not only has this strategy proved largely unsuccessful in 
providing additional data, for example in the collection of malaria aid expenditures 
(Narasimhan and Attaran 2003), it threatens to undermine more established and official 
systems of data collection.  
 
Getting evidence into policy 
Even when quality data on health resources are available, there is no guarantee that they 
will be used to inform policymaking. The challenge of getting evidence into policy is not 
new, nor is it limited to developing countries or health resource tracking. Nonetheless, it 
remains an important issue in this context. Evidence-based policymaking is an inherently 
complex and political process (Sutcliffe and Court 2005) and has been given limited 
attention in the resource tracking literature. One exception is a review of 21 countries, 
which analyses how NHA has impacted upon health policy and provides policy stories as 
illustrative examples from a broad range of developing countries (De, et al. 2003).  In 
total 19 countries reported at least one instance of NHA findings being used to inform 
policy, suggesting governments do place value on NHA findings. There is a need for 
further qualitative research into the policy uses of health resource tracking both to 
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strengthen the case for the development of these systems and to focus attention on how to 
increase evidence-based policymaking.  
 
6. Discussion 
Health resource tracking has seen encouraging advances in recent years in the 
standardisation of methods and availability of health expenditure data. However, there 
remains a conflict between satisfying short-term data needs and building systems and 
capacity in the long-term. 
 
The working group convened by CGD (Global Health Resource Tracking Working 
Group 2005) identified a core set of basic principles to guide the international donor 
community in their support for health resource tracking. They include: responding first 
and foremost to the needs of in-country policymakers; coordinating and aligning their 
support; utilising modern information management systems; and thinking long-term. 
While these ground rules and the recommendations which they underpin address closely 
the main issues in health resource tracking, it is unclear to what extent donors have an 
effective role to play in improving country level information systems upon which NHA 
should depend. Experience suggests donor-driven reforms in public expenditure 
management and conditionality more broadly have met with few successes (Foster and 
Killick 2006). Rather, the role of donors should be limited to technical capacity building. 
Genuine government accountability is generated when there is political pressure from 
within, from service beneficiaries and users on service providers, supported by an 
independent audit office, effective parliamentary scrutiny and civil society (Roberts 
2003). 
 
Donors have a clear role to play in providing recipient governments with timely data on 
their aid activities, and at the global level for the tracking of aid flows by sector and sub-
sector. Central to this is again the issue of accountability. Bilateral do nor organisations 
are accountable to their domestic electorate and lack the incentive to provide recipient 
countries or the international community with detailed information on their aid activities 
and commitments. Unless compelled to do so, donors will typically avoid providing 
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information that might be used to identify poor performance or that impose additional 
burdens on stretched administrations. The most promising first step forward in this regard 
is implementation of the principles laid out in the Paris Declaration on Aid Effectiveness 
(OECD 2005).  
 
There is a growing need to standardise methods for tracking donor aid to specific diseases 
to ensure that estimates are consistent, particularly in the apportionment of integrated 
health funds. At the same time, it should be recognised that these techniques provide 
indicative estimates only, which will become increasingly problematic as more donors 
move towards budget support funding. Moreover, there is a danger that advocacy efforts, 
for which the data are typically used, place pressure on donors to channel (and account 
for) funds in a vertical manner using separate parallel systems, when there is a growing 
consensus that health system strengthening and integrated funding flows are what is 
required (Travis, et al. 2004). 
 
Health resource tracking and public expenditure management may not be the most 
emotive issues on the development agenda, but they are key in providing the robust 
information base needed to develop equitable financing policies and ensure health 
resources are effectively mobilised and allocated.  
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